StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Neuroone Medical Technologies's profit margin for the twelve months ending Jun 30, 2026 was -78.6%. For fiscal 2025 it was -39.6%, against -356.7% the year before. The highest annual figure on record is -39.6% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 2025-39.6%+317.1
FY2024Sep 30, 2024-356.7%+250.7
FY2023Sep 30, 2023-607.4%+5234.5
FY2022Sep 30, 2022-5842.0%−257.7
FY2021Sep 30, 2021-5584.3%−895.5
FY2014Dec 31, 2014-4688.7%−2242.5
FY2013Dec 31, 2013-2446.3%−930.5
FY2012Dec 31, 2012-1515.7%−1004.4
FY2011Dec 31, 2011-511.4%+6.5
FY2010Dec 31, 2010-517.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 2026-101.7%−13.2
Q2 FY2026CQ1 2026Mar 31, 2026-127.9%+35.8
Q1 FY2026CQ4 2025Dec 31, 2025-49.7%−104.2
Q4 FY2025CQ3 2025Sep 30, 2025-59.1%+1171.5
Q3 FY2025CQ2 2025Jun 30, 2025-88.5%+246.7
Q2 FY2025CQ1 2025Mar 31, 2025-163.8%+43.5
Q1 FY2025CQ4 2024Dec 31, 202454.5%+396.7
Q4 FY2024CQ3 2024Sep 30, 2024-1230.6%−807.9
Q3 FY2024CQ2 2024Jun 30, 2024-335.1%+215.5
Q2 FY2024CQ1 2024Mar 31, 2024-207.3%+548.4
Q1 FY2024CQ4 2023Dec 31, 2023-342.1%+1170.2
Q4 FY2023CQ3 2023Sep 30, 2023-422.6%+1575.3
Q3 FY2023CQ2 2023Jun 30, 2023-550.7%+8060.3
Q2 FY2023CQ1 2023Mar 31, 2023-755.7%+7603.3
Q1 FY2023CQ4 2022Dec 31, 2022-1512.3%+6806.6
Q4 FY2022CQ3 2022Sep 30, 2022-1997.9%+3470.4
Q3 FY2022CQ2 2022Jun 30, 2022-8611.0%−1249.6
Q2 FY2022CQ1 2022Mar 31, 2022-8359.0%+4765.5
Q1 FY2022CQ4 2021Dec 31, 2021-8318.9%−5577.4
Q4 FY2021CQ3 2021Sep 30, 2021-5468.3%+4782.1
Q3 FY2021CQ2 2021Jun 30, 2021-7361.4%−1411.4
Q2 FY2021CQ1 2021Mar 31, 2021-13124.5%–
Q1 FY2021CQ4 2020Dec 31, 2020-2741.5%–
Q1 FY2015CQ1 2015Mar 31, 2015-10250.4%–
Q4 FY2014CQ4 2014Dec 31, 2014-5950.0%–

More Neuroone Medical Technologies figures

See a number that looks wrong?